CHEALEMBIC deferasirox 180 mg film-coated tablet blister pack

Land: Australia

Språk: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv ingrediens:

deferasirox, Quantity: 180 mg

Tilgjengelig fra:

Alembic Pharmaceuticals Australia Pty Ltd

Legemiddelform:

Tablet, film coated

Sammensetning:

Excipient Ingredients: crospovidone; microcrystalline cellulose; poloxamer; magnesium stearate; colloidal anhydrous silica; sodium starch glycollate type A; povidone; titanium dioxide; indigo carmine aluminium lake; hypromellose; purified talc; macrogol 4000

Administreringsrute:

Oral

Enheter i pakken:

30

Resept typen:

(S4) Prescription Only Medicine

Indikasjoner:

The treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adults and paediatric patients 6 years and older. CHEALEMBIC is also indicated for the treatment of chronic iron overload in paediatric patients aged 2 to 5 years who are unable to take desferrioxamine therapy or in whom desferrioxamine has proven ineffective. ,CHEALEMBIC is also indicated for the treatment of chronic iron overload in patients with non-transfusion- dependent thalassemia syndromes aged 10 years and older.

Produkt oppsummering:

Visual Identification: Medium blue, oval, biconvex, film-coated tablet with beveled edges, debossed with "L" on one side and "664" on the other side. Approximately 13 mm in length and approximately 5 mm in width.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorisasjon status:

Licence status A

Autorisasjon dato:

2020-11-16